The primary tumor treated with CPMV and its combinations contained more CD4+ T cells than the distant tumor, suggesting CPMV can directly recruit CD4+ T cells into the tumor microenvironment (Figure S9B, Supporting Information). Here, CD4 is linked to neoplasm.